Video Immunotherapies, Antibody Drug Conjugants Among Advances in Endometrial Cancer Treatment Options
News Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant
News New Approach to Adoptive T-Cell Therapy Shows Promise for Boosting Immune Response in Ovarian Cancer
News Unique Clinical Trial at Roswell Park Explores Complement Inhibitor for Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer with Malignant Effusion
BROADCASTMED